![Could A New Typhoid Vaccine End The Most Misdiagnosed Disease In Nigeria? | by Nigeria Health Watch | Medium Could A New Typhoid Vaccine End The Most Misdiagnosed Disease In Nigeria? | by Nigeria Health Watch | Medium](https://miro.medium.com/v2/resize:fit:1400/0*Sfkycwl0MVibu4vc.jpg)
Could A New Typhoid Vaccine End The Most Misdiagnosed Disease In Nigeria? | by Nigeria Health Watch | Medium
![Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial - The Lancet Global Health Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial - The Lancet Global Health](https://www.thelancet.com/cms/attachment/a111547c-5b8a-46d3-8e59-24d0a225b5f0/gr1_lrg.gif)
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial - The Lancet Global Health
![Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial - The Lancet Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/3d58ef63-24f8-43d5-a1ab-7944574490ed/gr1.gif)